Exploring Inhibitor Release Pathways in Histone Deacetylases Using Random Acceleration Molecular Dynamics Simulations

Molecular channel exploration perseveres to be the prominent solution for eliciting structure and accessibility of active site and other internal spaces of macromolecules. The volume and silhouette characterization of these channels provides answers for the issues of substrate access and ligand swapping between the obscured active site and the exterior of the protein. Histone deacetylases (HDACs) are metal-dependent enzymes that are involved in the cell growth, cell cycle regulation, and progression, and their deregulations have been linked with different types of cancers. Hence HDACs, especially the class I family, are widely recognized as the important cancer targets, and the characterizations of their structures and functions have been of special interest in cancer drug discovery. The class I HDACs are known to possess two different protein channels, an 11 Å and a 14 Å (named channels A and B1, respectively), of which the former is a ligand or substrate occupying tunnel that leads to the buried active site zinc ion and the latter is speculated to be involved in product release. In this work, we have carried out random acceleration molecular dynamics (RAMD) simulations coupled with the classical molecular dynamics to explore the release of the ligand, N-(2-aminophenyl) benzamide (LLX) from the active sites of the recently solved X-ray crystal structure of HDAC2 and the computationally modeled HDAC1 proteins. The RAMD simulations identified significant structural and dynamic features of the HDAC channels, especially the key 'gate-keeping' amino acid residues that control these channels and the ligand release events. Further, this study identified a novel and unique channel B2, a subchannel from channel B1, in the HDAC1 protein structure. The roles of water molecules in the LLX release from the HDAC1 and HDAC2 enzymes are also discussed. Such structural and dynamic properties of the HDAC protein channels that govern the ligand escape reactions will provide further mechanistic insights into the HDAC enzymes, which, in the long run, have a potential to bring new ideas for developing more promising HDAC inhibitors as well as extend our atomic level understandings on their mechanisms of action.

[1]  J. Sussman,et al.  An electrostatic mechanism for substrate guidance down the aromatic gorge of acetylcholinesterase. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[2]  K. Schulten,et al.  Calculating potentials of mean force from steered molecular dynamics simulations. , 2004, The Journal of chemical physics.

[3]  Joshua Close,et al.  Exploration of the internal cavity of histone deacetylase (HDAC) with selective HDAC1/HDAC2 inhibitors (SHI-1:2). , 2008, Bioorganic & medicinal chemistry letters.

[4]  Motonori Ota,et al.  PSCDB: a database for protein structural change upon ligand binding , 2011, Nucleic Acids Res..

[5]  Jung-Hsin Lin,et al.  Statins increase p21 through inhibition of histone deacetylase activity and release of promoter-associated HDAC1/2. , 2008, Cancer research.

[6]  Ping Zhu,et al.  Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis. , 2004, Cancer cell.

[7]  Hao Tang,et al.  Novel Inhibitors of Human Histone Deacetylase (HDAC) Identified by QSAR Modeling of Known Inhibitors, Virtual Screening, and Experimental Validation , 2009, J. Chem. Inf. Model..

[8]  Yong Duan,et al.  Chromophore channeling in the G-protein coupled receptor rhodopsin. , 2007, Journal of the American Chemical Society.

[9]  N. Dyson,et al.  Molecular mechanisms of E2F-dependent activation and pRB-mediated repression , 2004, Journal of Cell Science.

[10]  M Karplus,et al.  Zinc binding in proteins and solution: A simple but accurate nonbonded representation , 1995, Proteins.

[11]  R. Wade,et al.  Comparison of the dynamics of substrate access channels in three cytochrome P450s reveals different opening mechanisms and a novel functional role for a buried arginine , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Y. Duan,et al.  Ligand entry and exit pathways in the beta2-adrenergic receptor. , 2009, Journal of molecular biology.

[13]  Zbynek Prokop,et al.  Pathways and mechanisms for product release in the engineered haloalkane dehalogenases explored using classical and random acceleration molecular dynamics simulations. , 2009, Journal of molecular biology.

[14]  Stuart L Schreiber,et al.  Deacetylase enzymes: biological functions and the use of small-molecule inhibitors. , 2002, Chemistry & biology.

[15]  James E. Bradner,et al.  Chemical Phylogenetics of Histone Deacetylases , 2010, Nature chemical biology.

[16]  M. Navre,et al.  Exploration of the HDAC2 foot pocket: Synthesis and SAR of substituted N-(2-aminophenyl)benzamides. , 2010, Bioorganic & medicinal chemistry letters.

[17]  P. Marks,et al.  Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors , 1999, Nature.

[18]  J. Mccammon,et al.  Conformation gating as a mechanism for enzyme specificity. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[19]  陈奕欣.  Ongoing and future developments at the Universal Protein Resource , 2011 .

[20]  A. V. van Kuilenburg,et al.  Histone deacetylases (HDACs): characterization of the classical HDAC family. , 2003, The Biochemical journal.

[21]  Karl-Eric Magnusson,et al.  Effects of Histone Deacetylase Inhibitors, Sodium Phenyl Butyrate and Vitamin B3, in Combination with Retinoic Acid on Granulocytic Differentiation of Human Promyelocytic Leukemia HL‐60 Cells , 2006, Annals of the New York Academy of Sciences.

[22]  John P. Overington,et al.  ChEMBL: a large-scale bioactivity database for drug discovery , 2011, Nucleic Acids Res..

[23]  Maria Simonsson,et al.  The Balance between Acetylation and Deacetylation Controls Smad7 Stability* , 2005, Journal of Biological Chemistry.

[24]  Difei Wang,et al.  Computational studies on the histone deacetylases and the design of selective histone deacetylase inhibitors. , 2009, Current topics in medicinal chemistry.

[25]  A. Kalita,et al.  Substituted N-(2-aminophenyl)-benzamides, (E)-N-(2-aminophenyl)-acrylamides and their analogues: novel classes of histone deacetylase inhibitors. , 2006, Bioorganic & medicinal chemistry letters.

[26]  C. Fierke,et al.  On the function of the internal cavity of histone deacetylase protein 8: R37 is a crucial residue for catalysis. , 2011, Bioorganic & medicinal chemistry letters.

[27]  K. Dill,et al.  Binding of small-molecule ligands to proteins: "what you see" is not always "what you get". , 2009, Structure.

[28]  Edwin Smith,et al.  The Language of Histone Crosstalk , 2010, Cell.

[29]  R. Wade,et al.  How do substrates enter and products exit the buried active site of cytochrome P450cam? 1. Random expulsion molecular dynamics investigation of ligand access channels and mechanisms. , 2000, Journal of molecular biology.

[30]  Z. Xiang,et al.  On the role of the crystal environment in determining protein side-chain conformations. , 2002, Journal of molecular biology.

[31]  A. Cavalli,et al.  Single-molecule pulling simulations can discern active from inactive enzyme inhibitors. , 2010, Journal of the American Chemical Society.

[32]  Volkhard Helms,et al.  Protein dynamics tightly connected to the dynamics of surrounding and internal water molecules. , 2007, Chemphyschem : a European journal of chemical physics and physical chemistry.

[33]  Tao Liu,et al.  Histone deacetylase inhibitors: multifunctional anticancer agents. , 2006, Cancer treatment reviews.

[34]  T. Yamato,et al.  Visualizing breathing motion of internal cavities in concert with ligand migration in myoglobin , 2009, Proceedings of the National Academy of Sciences.

[35]  M. Salto‐Tellez,et al.  Inhibition of histone deacetylase 2 increases apoptosis and p21Cip1/WAF1 expression, independent of histone deacetylase 1 , 2005, Cell Death and Differentiation.

[36]  Rebecca C Wade,et al.  The ins and outs of cytochrome P450s. , 2007, Biochimica et biophysica acta.

[37]  B. Brooks,et al.  Constant pressure molecular dynamics simulation: The Langevin piston method , 1995 .

[38]  Ting Wang,et al.  Retinal release from opsin in molecular dynamics simulations , 2011, Journal of molecular recognition : JMR.

[39]  Ruibo Wu,et al.  A proton-shuttle reaction mechanism for histone deacetylase 8 and the catalytic role of metal ions. , 2010, Journal of the American Chemical Society.

[40]  P. Atadja,et al.  Human HDAC isoform selectivity achieved via exploitation of the acetate release channel with structurally unique small molecule inhibitors. , 2011, Bioorganic & medicinal chemistry.

[41]  Christopher B. Harrison,et al.  Structural origin of selectivity in class II-selective histone deacetylase inhibitors. , 2008, Journal of medicinal chemistry.

[42]  Adriano Martinelli,et al.  Docking of Hydroxamic Acids into HDAC1 and HDAC8: A Rationalization of Activity Trends and Selectivities , 2009, J. Chem. Inf. Model..

[43]  Masaaki Kawata,et al.  Particle mesh Ewald method for three-dimensional systems with two-dimensional periodicity , 2001 .

[44]  A. Laio,et al.  Metadynamics: a method to simulate rare events and reconstruct the free energy in biophysics, chemistry and material science , 2008 .

[45]  Rebecca C Wade,et al.  Do mammalian cytochrome P450s show multiple ligand access pathways and ligand channelling? , 2005, EMBO reports.

[46]  G. Estiu,et al.  Residues in the 11 A channel of histone deacetylase 1 promote catalytic activity: implications for designing isoform-selective histone deacetylase inhibitors. , 2008, Journal of medicinal chemistry.

[47]  Jin Ho Kim,et al.  Histone Deacetylase Inhibitor–Mediated Radiosensitization of Human Cancer Cells: Class Differences and the Potential Influence of p53 , 2006, Clinical Cancer Research.

[48]  Mark S. P. Sansom,et al.  Structure and Dynamics of the Membrane-Bound Cytochrome P450 2C9 , 2011, PLoS Comput. Biol..

[49]  Richard H. Henchman,et al.  The dynamics of ligand barrier crossing inside the acetylcholinesterase gorge. , 2003, Biophysical journal.

[50]  Dong Long,et al.  Molecular Dynamics Simulation of Ligand Dissociation from Liver Fatty Acid Binding Protein , 2009, PloS one.

[51]  A. Kalita,et al.  4-(Heteroarylaminomethyl)-N-(2-aminophenyl)-benzamides and their analogs as a novel class of histone deacetylase inhibitors. , 2008, Bioorganic & medicinal chemistry letters.

[52]  Jung-Hsin Lin,et al.  Statins Increase p 21 through Inhibition of Histone Deacetylase Activity and Release of Promoter-Associated HDAC 1 / 2 , 2008 .

[53]  V. S. Lamzin,et al.  From atoms to proteins , 2007, Cellular and Molecular Life Sciences.

[54]  M. Dokmanovic,et al.  Prospects: Histone deacetylase inhibitors , 2005, Journal of cellular biochemistry.

[55]  R. Friesner,et al.  Evaluation and Reparametrization of the OPLS-AA Force Field for Proteins via Comparison with Accurate Quantum Chemical Calculations on Peptides† , 2001 .

[56]  L. Aaltonen,et al.  A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition , 2006, Nature Genetics.

[57]  R. Marmorstein,et al.  Chemistry of acetyl transfer by histone modifying enzymes: structure, mechanism and implications for effector design , 2007, Oncogene.

[58]  O. Wiest,et al.  On the function of the 14 A long internal cavity of histone deacetylase-like protein: implications for the design of histone deacetylase inhibitors. , 2004, Journal of medicinal chemistry.

[59]  C. Abrams,et al.  Ligand escape pathways and (un)binding free energy calculations for the hexameric insulin-phenol complex. , 2008, Biophysical journal.

[60]  Ivars Kalvinsh,et al.  Novel amide derivatives as inhibitors of histone deacetylase: design, synthesis and SAR. , 2009, European journal of medicinal chemistry.

[61]  M. Grunstein.  Histone acetylation in chromatin structure and transcription , 1997, Nature.

[62]  Guang Song,et al.  Efficient mapping of ligand migration channel networks in dynamic proteins , 2011, Proteins.

[63]  Laxmikant V. Kale,et al.  NAMD2: Greater Scalability for Parallel Molecular Dynamics , 1999 .

[64]  Haishan Wang,et al.  New patented histone deacetylase inhibitors , 2009, Expert opinion on therapeutic patents.

[65]  D. Mottet,et al.  Histone deacetylases: target enzymes for cancer therapy , 2007, Clinical & Experimental Metastasis.

[66]  Matthieu Schapira,et al.  Structural biology of human metal-dependent histone deacetylases. , 2011, Handbook of experimental pharmacology.

[67]  R. De Francesco,et al.  Crystal structure of a eukaryotic zinc-dependent histone deacetylase, human HDAC8, complexed with a hydroxamic acid inhibitor. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[68]  Manel Esteller,et al.  The role of histone deacetylases (HDACs) in human cancer , 2007, Molecular oncology.

[69]  Or Gozani,et al.  Decoding Chromatin Goes High Tech , 2010, Cell.

[70]  Yuji Nagata,et al.  Redesigning dehalogenase access tunnels as a strategy for degrading an anthropogenic substrate. , 2009, Nature chemical biology.

[71]  A. Laio,et al.  Escaping free-energy minima , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[72]  M. Karplus,et al.  CHARMM: A program for macromolecular energy, minimization, and dynamics calculations , 1983 .

[73]  I M Kovach,et al.  Efficient product clearance through exit channels in substrate hydrolysis by acetylcholinesterase , 1994, FEBS letters.

[74]  T. Halgren.  Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94 , 1996, J. Comput. Chem..

[75]  Ruibo Wu,et al.  Zinc chelation with hydroxamate in histone deacetylases modulated by water access to the linker binding channel. , 2011, Journal of the American Chemical Society.

[76]  B. Honig,et al.  A hierarchical approach to all‐atom protein loop prediction , 2004, Proteins.

[77]  Anton V. Bieliauskas,et al.  Isoform-Selective Histone Deacetylase Inhibitors , 2008 .

[78]  Weihua Li,et al.  Exploring coumarin egress channels in human cytochrome p450 2a6 by random acceleration and steered molecular dynamics simulations , 2011, Proteins.

[79]  VINCENT ZOETE,et al.  SwissParam: A fast force field generation tool for small organic molecules , 2011, J. Comput. Chem..